22.39% | % of shares held by all insiders |
72.58% | % of shares held by institutions |
93.53% | % of float held by institutions |
359 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
SB Investment Advisers (UK) LTD | 73,031,667 | 30 Mar 2024 | 9.89% | 788,742,017 |
Viking Global Investors, L.P. | 69,368,961 | 30 Mar 2024 | 9.39% | 749,184,792 |
QVT Financial LP | 66,719,779 | 30 Mar 2024 | 9.03% | 720,573,625 |
Blackrock Inc. | 36,187,519 | 30 Mar 2024 | 4.90% | 390,825,212 |
Morgan Stanley | 35,635,501 | 30 Mar 2024 | 4.82% | 384,863,417 |
FMR, LLC | 35,340,563 | 30 Mar 2024 | 4.78% | 381,678,087 |
Rubric Capital Management LP | 20,000,000 | 30 Mar 2024 | 2.71% | 216,000,003 |
State Street Corporation | 17,153,134 | 30 Mar 2024 | 2.32% | 185,253,850 |
Patient Square Capital LP | 12,228,465 | 30 Mar 2024 | 1.66% | 132,067,424 |
Woodline Partners LP | 11,172,306 | 30 Mar 2024 | 1.51% | 120,660,906 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Fidelity Growth Company Fund | 14,430,922 | 30 May 2024 | 1.95% | 155,853,960 |
iShares Core S&P Midcap ETF | 10,545,001 | 29 Jun 2024 | 1.43% | 113,886,012 |
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 8,332,440 | 29 Jun 2024 | 1.13% | 89,990,353 |
Vanguard Extended Market Index Fund | 5,085,818 | 30 Mar 2024 | 0.69% | 54,926,835 |
Fidelity Growth Company K6 Fund | 4,815,666 | 30 May 2024 | 0.65% | 52,009,193 |
Fidelity Series Growth Company Fund | 3,833,600 | 30 May 2024 | 0.52% | 41,402,880 |
Morgan Stanley Inst Fd Inc-Growth Port | 3,789,733 | 30 Mar 2024 | 0.51% | 40,929,117 |
Invesco ETF Tr-Invesco S&P MidCap Quality ETF | 3,733,634 | 29 Jun 2024 | 0.51% | 40,323,247 |
iShares Biotechnology ETF | 3,772,474 | 29 Jun 2024 | 0.51% | 40,742,719 |
Fidelity Select Portfolios - Biotechnology | 3,422,619 | 30 May 2024 | 0.46% | 36,964,285 |